Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Headache
Prif Awduron: Rosen, Noah, Pearlman, Eric, Ruff, Dustin, Day, Kathleen, Nagy, Abraham Jim
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2019
Pynciau:
Comments, Observations, and Rebuttals
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6594135/
https://ncbi.nlm.nih.gov/pubmed/30973202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.13514
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg